Hence, it is tempting to speculate that SETD2/H3K36me3 deficiency synergizes with BCR::ABL1 to enhance genetic instability over the threshold that is necessary and sufficient to promote and/or sustain disease acceleration/progression that may ultimately lead to BC. Here, ABL1 is linked to breast cancer.